Review
Published on 07 Apr 2025
The role of immunotherapy in targeting tumor microenvironment in genitourinary cancers
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1506278
- 473 views
Type at least 3 characters
7,540 articles
Original Research
Published on 07 Apr 2025
Analysis of prognostic factors and nomogram construction for postoperative survival of triple-negative breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1561563
- 392 views
Review
Published on 07 Apr 2025
Ferroptosis: a novel perspective on tumor immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1524711
- 401 views
Editorial
Published on 07 Apr 2025
Editorial: Tumor-associated tertiary lymphoid structures response during immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1591820
- 275 views
Clinical Trial
Published on 07 Apr 2025
Neoadjuvant sintilimab and chemotherapy for resectable esophageal squamous cell carcinoma: a phase II clinical trial
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1486275
- 286 views
Original Research
Published on 07 Apr 2025
Development and validation of a 16-gene T-cell- related prognostic model in non-small cell lung cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1566597
- 524 views
Original Research
Published on 07 Apr 2025
Using body composition to predict treatment-related adverse events and disease-free survival in patients with gastrointestinal stromal tumors treated with imatinib: a retrospective cohort study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1576834
- 382 views
Systematic Review
Published on 07 Apr 2025
Application and prospect analysis of chimeric antigen receptor T-cell therapy in hepatocellular carcinoma treatment: a systematic review and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1566976
- 391 views
Original Research
Published on 07 Apr 2025
ARIH2 serves as a potential prognostic biomarker for hepatocellular carcinoma associated with immune infiltration and ferroptosis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1548691
- 378 views
Original Research
Published on 07 Apr 2025
Glucose deprivation and identification of TXNIP as an immunometabolic modulator of T cell activation in cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1548509
- 689 views
Case Report
Published on 07 Apr 2025
Both complete response and long-term survival after combination therapy with toripalimab in a patient with meta-oligometastases cervical cancer: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1542795
- 301 views
Original Research
Published on 07 Apr 2025
Combination of anlotinib with immunotherapy enhanced both anti-angiogenesis and immune response in high-grade serous ovarian cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1539616
- 308 views
Review
Published on 07 Apr 2025
Mechanisms of HDACs in cancer development
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1529239
- 351 views
Original Research
Accepted on 04 Apr 2025
Immune Architecture in Stage III and IV Melanoma Identifies Distinct Patient Subgroups
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1560778
- 134 views
Review
Accepted on 04 Apr 2025
The mechanism of action and therapeutic potential of tumor-associated macrophages in tumor immune evasion
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1545928
Original Research
Accepted on 04 Apr 2025
Clinical Manifestations and Risk Factors of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1 Inhibitors: A Case-Control Study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1581057